The Novel Use of Postbiotics of TYCA06/AP-32/CP-9 in the Amelioration of Atopic Dermatitis and Improvement of Skin Care - A Clinical Study

Hsieh-Hsun Ho¹, Ching-Wei Chen¹, Yu-Fen Huang¹, Yi-Wei Kuo¹, Jia-Hung Lin¹, Jui-Fen Chen¹, Chen-Hung Hsu¹, Tsai-Hsuan Yi¹, Leong-Perng Chan^{2, 3,} and Chia-Hua Liang^4,

¹Glac Biotech Co., Ltd., Tainan City 74442, Taiwan

²Department of Otorhinolaryngology-Head and Neck Surgery, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan

³Department of Otorhinolaryngology-Head and Neck Surgery, Kaohsiung Medical University Hospital, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

⁴Department of Cosmetic Science and Institute of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan

Cite this paper:
Hsieh-Hsun Ho, Ching-Wei Chen, Yu-Fen Huang, Yi-Wei Kuo, Jia-Hung Lin, Jui-Fen Chen, Chen-Hung Hsu, Tsai-Hsuan Yi, Leong-Perng Chan and Chia-Hua Liang. The Novel Use of Postbiotics of TYCA06/AP-32/CP-9 in the Amelioration of Atopic Dermatitis and Improvement of Skin Care - A Clinical Study. International Journal of Clinical and Diagnostic Research. 2021; 9(1):18-28. doi: 10.12691/ijcdr-9-1-3

Abstract

The development of human society has created many synthetic materials for better convenience; however, these innovated products usually produce unnatural side chemicals in the environment. The skin is the first barrier of defense against pathogens and toxicants, so the health of skin is important not only on facial appearance but also on physical health. Many people live a busy life and the habit of refined diet and over-cleaning does not improve the quality of life. In contrary, the overuse of detergents and antibiotics may cause skin dysbiosis, and result in a sensitive skin, aging skin, or, moreover, atopic dermatitis. In this study, the postbiotic blend of three probiotic strains, TYCA06/AP-32/CP-9 (TAC), displayed the growth inhibition against Staphylococcus aureus, and the stimulation of the anti-inflammatory cytokine in vitro, such as transforming growth factor (TGF)-β and interleukin (IL)-10. This TAC formula enhanced the wound healing in keratinocytes HaCaT cell culture and increased moisture content on skin in vivo. The TAC formula was further incorporated into a cosmetic lotion, and the human clinical trial was carried out by applying this lotion on volunteers’ face or hand with atopic dermatitis (AD). The result showed the TAC lotion improved the moisture score, inflammation index, and brightening score of the skin. In addition, this TAC lotion also improved the wound repair of cracked skin in volunteers with AD. Moreover, this TAC lotion reduced the number of the speckle and wrinkles on facial skin. Taken together, this postbiotic blend of TAC has beneficial effects on skin health, and is able to ameliorate the red and itchy skin in AD patients.

Keywords:
postbiotics skin atopic dermatitis

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Azimi, E., Xia, J., Lerner, E.A., Peripheral mechanisms of Itch. Curr Probl Dermatol. 50, 18-23, 2016.
[2]	Thomsen, S.F., Atopic dermatitis: natural history, diagnosis, and treatment. ISRN Allergy. 354250, 2014.
[3]	Grey, K., Maguiness, S., Atopic dermatitis: update for pediatricians. Pediatr Ann. 45(8), 280-286, 2016.
[4]	Goh, C.L., Wong, J.S.,Giam, Y.C., Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol. 36(9), 653-657, 1997.
[5]	Nakatsuji, T., Chen, T.H., Two, A.M., Chun, K.A., Narala, S., Geha, R.S., Hata, T.R., Gallo, R.L., Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression. J. Invest. Dermatol. 136(11), 2192-2200, 2016.
[6]	Baquerizo Nole, K.L., Yim, E., Keri, J.E., Probiotics and prebiotics in dermatology. J. Am. Acad. Dermatol. 71(4), 814-821, 2014.
[7]	Lise, M., Mayer, I., Silveira, M., Use of probiotics in atopic dermatitis. Rev. Assoc. Med. Bras. 64(11), 997-1001, 2018.
[8]	Murillo, N., Raoult, D., Skin microbiota: overview and role in the skin diseases acne vulgaris and rosacea. Future Microbiol. 8(2), 209-222, 2013.
[9]	Zeeuwen, P.L., Kleerebezem, M., Timmerman, H.M., Schalkwijk, J., Microbiome and skin diseases. Curr. Opin. Allergy Clin. Immunol. 13(5), 514-520, 2013.
[10]	Myles, I.A., Earland, N.J., Anderson, E.D., Moore, I.N., Kieh, M.D., Williams, K.W., Saleem, A., Fontecilla, N.M., Welch, P.A., Darnell, D.A., Barnhart, L.A., Sun, A.A., Uzel, G., Datta, S.K., First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight. 3(9), e120608, 2018.
[11]	Simpson, P., Good bacteria for healthy skin; Ulysses Press; Berkely, CA, USA, Chapter 6, p85-103, 2019.
[12]	Hiraishi, A., Direct automated sequencing of 16S rDNA amplified by polymerase chain reaction from bacterial cultures without DNA purification. Lett. Appl. Microbiol. 15, 210-213, 1992.
[13]	Stackebrandt, E., Goodfellow, M., Nucleic acid techniques in bacterial systematics. Chichester.; Wiley: New York, NY, USA, p115-175, 1991.
[14]	Weisburg, W.G., Barns, S.M., Pelletier, D.A., Lane, D.J., 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173, 697-703, 1991.
[15]	Strus, M., Kucharska, A., Kukla, G., Brzychczy-Włoch, M., Maresz, K., Heczko, P.B., The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect. Dis. Obstet. Gynecol. 13(2), 69-75, 2005.
[16]	Liu, Y.S., Wu, J.F., Huang, C.C., Assessment of bacteriostatic activities of viable and non-viable lactic acid bacteria against methicillin-resistant Staphylococcus aureus. Basic Clin. Pharmacol. Toxicol. 125, S6, 14-15, 2019.
[17]	Montanari, C., Barbieri, F., Magnani, M., Grazia, L., Gardini, F., Tabanelli, G., Phenotypic diversity of Lactobacillus sakei strains. Front. Microbiol. 9, 2003, 2018.
[18]	Geoghegan, J.A., Irvine, A.D., Foster, T.J., Staphylococcus aureus and atopic dermatitis: A complex and evolving relationship. Trends Microbiol. 26(6), 484-497, 2018.
[19]	Aguilar-Toalá, J., Garcia-Varela, R., Garcia, H., Mata-Haro, V., González-Córdova, A., Vallejo-Cordoba, B., Hernández-Mendoza, A., Postbiotics: An evolving term within the functional foods field. Trends Food Sci. Technol. 75, 105-114, 2018.
[20]	Lukic, J., Chen, V., Strahinic, I., Begovic, J., Lev-Tov, H., Davis, S.C., Tomic-Canic, M., Pastar, I., Probiotics or pro-healers: the role of beneficial bacteria in tissue repair. Wound Repair Regen. 25(6), 912-922, 2017.
[21]	Giam, Y.C., Hebert, A.A., Dizon, M.V., Van Bever, H., Tiongco-Recto, M., Kim, K.H., Soebono, H., Munasir, Z., Diana, I.A., Luk, D.C., A review on the role of moisturizers for atopic dermatitis. Asia Pac. Allergy. 6(2), 120-128, 2016.
[22]	Vincent, J.G., Veimett, R.C., Riley, R.F., Antibacterial activity associated with Lactobacillus acidophilus. J. Bacteriol. 78(4), 477-484, 1959.
[23]	Ocaña, V.S., Pesce De Ruiz Holgado, A.A., Nader-Macías, M.E., Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl. Environ. Microbiol. 65(12), 5631-5635, 1999.
[24]	Pei, J., Yuan, Y., Yue, T., Characterization of bacteriocin bificin C6165: a novel bacteriocin. J. Appl. Microbiol. 114(5), 1273-1284, 2013.
[25]	Bomar, L., Brugger, S.D., Yost, B.H., Davies, S.S., Lemon, K.P., Corynebacterium accolens releases antipneumococcal free fatty acids from human nostril and skin surface triacylglycerols. mBio. 7(1), e01725-15, 2016.
[26]	Levy, M., Thaiss, C.A., Zeevi, D., Dohnalová, L., Zilberman-Schapira, G., Mahdi, J.A., David, E., Savidor, A., Korem, T., Herzig, Y., Pevsner-Fischer, M., Shapiro, H., Christ, A., Harmelin, A., Halpern, Z., Latz, E., Flavell, R.A., Amit, I., Segal, E., Elinav, E., Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell. 163(6). 1428-1443, 2015.
[27]	Azad, M., Sarker, M., Wan, D., Immunomodulatory effects of probiotics on cytokine profiles. BioMed Res. Int. 2018, 8063647, 2018.
[28]	Zago, M., Scaltriti, E., Bonvini, B., Fornasari, M.E., Penna, G., Massimiliano, L., Carminati, D., Rescigno, M., Giraffa, G., Genomic diversity and immunomodulatory activity of Lactobacillus plantarum isolated from dairy products. Benefic. Microbes. 8(4), 597-604, 2017.
[29]	Baquerizo Nole, K.L., Yim, E., Keri, J.E., Probiotics and prebiotics in dermatology. J. Am. Acad. Dermatol. 1(4), 814-821, 2014.
[30]	Varian, B. J., Poutahidis, T., DiBenedictis, B.T., Levkovich, T., Ibrahim, Y., Didyk, E., Shikhman, L., Cheung, H.K., Hardas, A., Ricciardi, C.E., Kolandaivelu, K., Veenema, A.H., Alm, E.J., Erdman, S.E., Microbial lysate upregulates host oxytocin. Brain, Behav., Immun. 61, 36-49, 2017.
[31]	Nakatsuji, T., Chen, T.H., Two, A.M., Chun, K.A., Narala, S., Geha, R.S., Hata, T.R., Gallo, R.L., Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression. J. Invest. Dermatol. 136(11), 2192-2200, 2016.
[32]	Ezerskaia, A., Pereira, S.F., Urbach, H.P., Verhagen, R., Varghese, B., Quantitative and simultaneous non-invasive measurement of skin hydration and sebum levels. Biomed. Opt. Express. 7(6), 2311-2320, 2016.
[33]	Del Rosso, J.Q., Levin, J., The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin. J. Clin. Aesthet. Dermatol. 4(9), 22-42, 2011.
[34]	Baumann, L., Rodriguez, D., Taylor, S.C., Wu, J., Natural considerations for skin of color. Cutis. 78(6 Suppl), 2-19, 2006.
[35]	Varian, B.J., Poutahidis, T., DiBenedictis, B.T., Levkovich, T., Ibrahim, Y, Didyk, E., Shikhman, L., Cheung, H.K., Hardas, A., Ricciardi, C.E., Kolandaivelu, K., Veenema, A.H., Alm, E.J., Erdman, S.E., Microbial lysate upregulates host oxytocin. Brain, Behav., Immun. 61, 36-49, 2017.